GW Pharma (GWPH) Posts Smaller-than-Expected Q1 Loss

GW Pharma (NASDAQ: GWPH) reported Q1 EPS of ($0.77), $0.92 better than the analyst estimate of ($1.69). Revenue for the quarter came in at $2.54 million versus the consensus estimate of $2.4 million.

For earnings history and earnings-related data on GW Pharma (GWPH) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• Yum! Brands (YUM) PT Lowered to $180 at Argus
• Vislink Technologies Inc. (VISL) Misses Q2 EPS by 7c